Page 1
No materials in this presentation may be repurposed in print or online without the express written permission of the American Joint Committee on Cancer. Permission requests may be submitted at cancerstaging.org.
Validating science. Improving patient care.
AJCC Staging Moments AJCC TNM Staging 8th Edition Melanoma Case #1
Page 2
Contributors: Jeffrey E. Gershenwald, MD, FACS The University of Texas MD Anderson Cancer Center Houston, Texas
Page 3
Copyright © 2018 AJCC All Rights Reserved 3
Melanoma Case # 1 Presentation of New Case
• Newly diagnosed melanoma patient
• Presentation at Cancer Conference for treatment recommendations and clinical staging
Page 4
Copyright © 2018 AJCC All Rights Reserved 4
Melanoma Case # 1 History & Physical
• 83 yr old female who presented with 2 cm maximal diameter brown lesion right cheek over right malar eminence; no clinical evidence of ulceration, cervical lymphadenopathy, in-transit or satellite disease
• No family hx of melanoma
Used with permission. Marghoob A, Halpern A. Atlas of Cancer. Edited by Maurie Markman, Ashfaq A. Marghoob. ©2002 Current Medicine, Inc.
Used with permission. Marghoob A, Halpern A. Atlas of Cancer. Edited by Maurie Markman, Ashfaq A. Marghoob. ©2002 Current Medicine, Inc.
Page 5
Copyright © 2018 AJCC All Rights Reserved 5
Melanoma Case # 1 Imaging Results
• No imaging
Page 6
Copyright © 2018 AJCC All Rights Reserved 6
Melanoma Case # 1 Diagnostic Procedure
• Diagnostic Procedure – Excision skin lesion right cheek
• Pathology Report
– Melanoma in situ – Lentigo maligna type – Peripheral margin involved
Page 7
Copyright © 2018 AJCC All Rights Reserved 7
Melanoma Case # 1 Clinical Staging
• Clinical staging – Uses information from physical exam, imaging, and diagnostic
biopsy including excision of primary tumor in melanoma – Excision of primary tumor includes shave bx, punch bx, incisional
bx, excisional bx, or complete excisional bx (microstaging)
• Purpose – Select appropriate treatment – Estimate prognosis
Page 8
Copyright © 2018 AJCC All Rights Reserved 8
Melanoma Case # 1 Clinical Staging
• Synopsis: patient with melanoma in situ with involved peripheral margin, no clinical lymphadenopathy
• What is the clinical stage? – T____ – N____ – M____ – Stage Group______
Page 9
Copyright © 2018 AJCC All Rights Reserved 9
Melanoma Case # 1 Clinical Staging
• Clinical Stage correct answer – cTis – cN0 – cM0 – Stage Group 0
• Based on stage, treatment is selected
• Review treatment guidelines for this stage
Page 10
Copyright © 2018 AJCC All Rights Reserved 10
Melanoma Case # 1 Clinical Staging
• Rationale for staging choices – cTis for melanoma in situ
– cN0 because nodes were clinically negative on physical exam*
– cM0 because there were no signs or symptoms to suggest distant
metastases*
– * Additional tests would likely be performed if evidence of regional or distant disease before developing a treatment plan
Page 11
Copyright © 2018 AJCC All Rights Reserved 11
Melanoma Case # 1 Treatment Options
• Review treatment guidelines for this stage
• Discuss appropriate treatment plans for this patient
Page 12
Copyright © 2018 AJCC All Rights Reserved 12
Melanoma Case # 1 Surgery & Findings
• Surgery – Re-excision with 5mm margin
• Operative findings
– No contributory information
Page 13
Copyright © 2018 AJCC All Rights Reserved 13
Melanoma Case # 1 Pathology Results
• Residual melanoma in situ
• Lentigo maligna melanoma
• Extends close to, but does not involve, radial margins; deep margins uninvolved
Page 14
Copyright © 2018 AJCC All Rights Reserved 14
Melanoma Case # 1 Pathological Staging
• Pathological staging – Uses information from clinical staging, operative findings, and
resected specimen pathology report
• Purpose – Additional precise data for estimating prognosis – Calculating end results (survival data)
Page 15
Copyright © 2018 AJCC All Rights Reserved 15
Melanoma Case # 1 Pathological Staging
• Synopsis: patient with melanoma in situ, no nodes removed, clinically nodes negative
• What is the pathological stage? • T____
– N____ – M____ – Stage Group______
Page 16
Copyright © 2018 AJCC All Rights Reserved 16
Melanoma Case # 1 Pathological Staging
• Pathological Stage - correct answer – pTis – cN0 – cM0 – Stage Group 0
Page 17
Copyright © 2018 AJCC All Rights Reserved 17
Melanoma Case # 1 Pathological Staging
• Rationale for staging choices – pTis for melanoma in situ
– cN0 because of exception for pathological Stage 0 and pT1
they do not require microscopic evaluation of nodes
– cM0 – use clinical M with pathological staging unless there is microscopic confirmation of distant metastasis
Page 18
Copyright © 2018 AJCC All Rights Reserved 18
Prognostic Factors/Registry Data Collection
• Applicable to this case
– Primary tumor thickness: not applicable
– Ulceration: not applicable
Page 19
Copyright © 2018 AJCC All Rights Reserved 19
Tis – melanoma in situ
Melanoma. In Compton, C.C., Byrd, D.R., et al. (Eds.) AJCC Cancer Staging Atlas, 2nd edition (2012)
Page 20
Copyright © 2018 AJCC All Rights Reserved 20
Melanoma Case # 1 Recap
• Summary of correct answers
– Clinical stage - cTis cN0 cM0 Stage Group 0
– Pathological stage - pTis cN0 cM0 Stage Group 0
• Staging classifications each have a different purpose and
method of assessment so can be different. Do not go back and change the clinical staging based on pathological staging information.
Page 21
Copyright © 2018 AJCC All Rights Reserved 21
Staging Moments Summary
• Review site-specific information if needed
• Clinical Staging – Based on information before treatment – Used to select treatment options
• Pathological Staging
– Based on clinical data PLUS operative findings and resected specimen pathology report
– Used to evaluate end results (e.g. survival)